INNOVA BIOSCIENCES LTD
Manufacture of basic pharmaceutical products
INNOVA BIOSCIENCES LTD
Manufacture of basic pharmaceutical products
Previous Company Names
Contact & Details
Contact
Registered Address
Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX England
Full company profile for INNOVA BIOSCIENCES LTD (04415674), an active company based in Cambridge, England. Incorporated 12 Apr 2002. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2013–2024)
Cash in Bank
N/A
Net Assets
£219.00k
Total Liabilities
£1.96M
Turnover
N/A
Employees
N/A
Debt Ratio
90%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 21 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (2)
Abcam Limited
United Kingdom
- Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Expedeon Holdings Limited
Unknown
- Ownership Of Shares 75 To 100 Percent
- Voting Rights 75 To 100 Percent
Sygnis Ag
Ceased 1 Jan 2020
Nicolas Steven Gee
Ceased 16 Jun 2017
Group Structure
Group Structure
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 29 Apr 2026 | Confirmation Statement | Confirmation statement made on 31 Mar 2026 with no updates | |
| 12 Nov 2025 | Officers | Appointment of Jonathan Peter Fogg as director on 31 Oct 2025 | |
| 12 Nov 2025 | Persons With Significant Control | Cessation of Abcam Limited as a person with significant control on 12 Nov 2025 | |
| 12 Nov 2025 | Persons With Significant Control | Expedeon Holdings Limited notified as a person with significant control | |
| 11 Nov 2025 | Officers | Termination of Nicola Ann Summers as director on 31 Oct 2025 |
Confirmation statement made on 31 Mar 2026 with no updates
Appointment of Jonathan Peter Fogg as director on 31 Oct 2025
Cessation of Abcam Limited as a person with significant control on 12 Nov 2025
Expedeon Holdings Limited notified as a person with significant control
Termination of Nicola Ann Summers as director on 31 Oct 2025
Recent Activity
Latest Activity
Confirmation statement made on 31 Mar 2026 with no updates
4 days ago on 29 Apr 2026
Appointment of Jonathan Peter Fogg as director on 31 Oct 2025
5 months ago on 12 Nov 2025
Cessation of Abcam Limited as a person with significant control on 12 Nov 2025
5 months ago on 12 Nov 2025
Expedeon Holdings Limited notified as a person with significant control
5 months ago on 12 Nov 2025
Termination of Nicola Ann Summers as director on 31 Oct 2025
5 months ago on 11 Nov 2025